The Europe Veterinary Orthopedic Implants Market was valued at USD 189.6 million in 2024 and is estimated to grow at a CAGR of 8.2% to reach USD 410.3 million by 2034.
This growth is fueled by the rising number of pets across Europe and an increasing incidence of orthopedic conditions such as fractures, ligament injuries, and joint diseases in companion animals. As the demand for advanced medical treatments in pets grows, the market for implants designed to restore bone function or replace damaged joints is gaining momentum. These implants, typically made from stainless steel or titanium, are now preferred over traditional options due to their superior strength, biocompatibility, and faster recovery outcomes. With the rise in complex injuries, veterinary hospitals and clinics are increasingly turning to high-performance fixation systems like locking plates and intramedullary nails for better stability and fewer complications. In addition, the adoption of minimally invasive surgical methods is transforming clinical practice, with surgeons opting for implants that support small-incision procedures and enable faster recovery, enhancing comfort for pets and confidence among owners.
In 2024, the implants segment generated USD 134.9 million and is forecasted to grow to USD 296.4 million by 2034. This growth is strongly tied to the rising pet population across Europe and the growing demand for premium orthopedic solutions. Increased awareness of advanced treatment options is encouraging pet owners to seek high-quality surgical care for conditions such as hip dysplasia, osteoarthritis, and cruciate ligament injuries. The prevalence of orthopedic issues in dogs continues to drive growth across veterinary clinics and hospitals.
The small and medium animals segment held a 72.3% share in 2024. In contrast, large animals represented a 27.7% share. Livestock such as goats, pigs, and sheep are essential to the region’s agriculture, and their exposure to orthopedic problems, often due to confined farming and rapid growth cycles, is pushing demand for surgical interventions in these species as well.
UK Veterinary Orthopedic Implants Market held a 16.5% share in 2024. The country’s strong veterinary infrastructure, high awareness levels among pet owners, and rising pet humanization trends have all contributed to increasing the number of orthopedic procedures. Urbanization, coupled with growing interest in premium pet care, is fueling the demand for treatments targeting arthritis, fractures, and joint issues in companion animals.
Leading participants in the Europe veterinary orthopedic implants industry include Veterinary Instrumentation, Arthrex Vet Systems, Integra LifeSciences, Orthomed, Ortho Max, Fusion Implants, Rita Leibinger, Movora (Vimian Group), AmerisourceBergen Corporation (Cencora, Inc.), Narang Medical Limited, GPC Medical Ltd., DePuy Synthes (Johnson & Johnson), BlueSAO, GerVetUSA, and B. Braun. To strengthen their foothold in the Europe Veterinary Orthopedic Implants Market, key players are focusing on expanding their product portfolios through innovation in implant materials and designs. Many are investing in R&D to create lightweight, durable, and biocompatible solutions that suit a wider range of animal sizes and conditions. Strategic partnerships with veterinary clinics and universities are also helping companies drive product adoption and expand their customer base. Additionally, several manufacturers are increasing their regional presence through distribution agreements and direct-to-vet marketing strategies, while offering hands-on training programs to support product utilization and build practitioner trust across Europe.
This product will be delivered within 2-4 business days.
This growth is fueled by the rising number of pets across Europe and an increasing incidence of orthopedic conditions such as fractures, ligament injuries, and joint diseases in companion animals. As the demand for advanced medical treatments in pets grows, the market for implants designed to restore bone function or replace damaged joints is gaining momentum. These implants, typically made from stainless steel or titanium, are now preferred over traditional options due to their superior strength, biocompatibility, and faster recovery outcomes. With the rise in complex injuries, veterinary hospitals and clinics are increasingly turning to high-performance fixation systems like locking plates and intramedullary nails for better stability and fewer complications. In addition, the adoption of minimally invasive surgical methods is transforming clinical practice, with surgeons opting for implants that support small-incision procedures and enable faster recovery, enhancing comfort for pets and confidence among owners.
In 2024, the implants segment generated USD 134.9 million and is forecasted to grow to USD 296.4 million by 2034. This growth is strongly tied to the rising pet population across Europe and the growing demand for premium orthopedic solutions. Increased awareness of advanced treatment options is encouraging pet owners to seek high-quality surgical care for conditions such as hip dysplasia, osteoarthritis, and cruciate ligament injuries. The prevalence of orthopedic issues in dogs continues to drive growth across veterinary clinics and hospitals.
The small and medium animals segment held a 72.3% share in 2024. In contrast, large animals represented a 27.7% share. Livestock such as goats, pigs, and sheep are essential to the region’s agriculture, and their exposure to orthopedic problems, often due to confined farming and rapid growth cycles, is pushing demand for surgical interventions in these species as well.
UK Veterinary Orthopedic Implants Market held a 16.5% share in 2024. The country’s strong veterinary infrastructure, high awareness levels among pet owners, and rising pet humanization trends have all contributed to increasing the number of orthopedic procedures. Urbanization, coupled with growing interest in premium pet care, is fueling the demand for treatments targeting arthritis, fractures, and joint issues in companion animals.
Leading participants in the Europe veterinary orthopedic implants industry include Veterinary Instrumentation, Arthrex Vet Systems, Integra LifeSciences, Orthomed, Ortho Max, Fusion Implants, Rita Leibinger, Movora (Vimian Group), AmerisourceBergen Corporation (Cencora, Inc.), Narang Medical Limited, GPC Medical Ltd., DePuy Synthes (Johnson & Johnson), BlueSAO, GerVetUSA, and B. Braun. To strengthen their foothold in the Europe Veterinary Orthopedic Implants Market, key players are focusing on expanding their product portfolios through innovation in implant materials and designs. Many are investing in R&D to create lightweight, durable, and biocompatible solutions that suit a wider range of animal sizes and conditions. Strategic partnerships with veterinary clinics and universities are also helping companies drive product adoption and expand their customer base. Additionally, several manufacturers are increasing their regional presence through distribution agreements and direct-to-vet marketing strategies, while offering hands-on training programs to support product utilization and build practitioner trust across Europe.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, by Product, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Animal Type, 2021-2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Application, 2021-2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)
Chapter 9 Market Estimates and Forecast, by Country, 2021-2034 ($ Mn)
Chapter 10 Company Profiles
Companies Mentioned
The companies profiled in this Europe Veterinary Orthopedic Implants market report include:- AmerisourceBergen Corporation (Cencora, Inc.)
- Arthrex Vet Systems
- B. Braun
- BlueSAO
- DePuy Synthes (Johnson & Johnson)
- Fusion Implants
- GerVetUSA
- GPC Medical Ltd.
- Integra LifeSciences
- Movora (Vimian Group)
- Narang Medical Limited
- Ortho Max
- Orthomed
- Rita Leibinger
- Veterinary Instrumentation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 128 |
| Published | October 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 189.6 Million |
| Forecasted Market Value ( USD | $ 410.3 Million |
| Compound Annual Growth Rate | 8.2% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 16 |
